On 08 February 2014
IOL Chemicals & Pharmaceuticals announced that its directors in board meeting held on 08 February 2014 have approved its extension of date for redemption of 7% non cumulative redeemable preference shares subject to shareholder's approval and authorized the managing director to explore the possibility of various options consisting of demerger or merger, incorporate one or more subsidiary companies, joint ventures and to transfer the business of one segment/product, or in combination or otherwise arrange the business of company to unleash the potential of the company.Powered by Capital Market - Live News